# EDGAR Filing Document

**Accession Number:** 0001005286
**File Stem:** 0000000000-25-010490
**Filing Date:** 2025-9
**Character Count:** 2252
**Document Hash:** 4d5fac39e01ad367e4e59ec6d1e8ae47
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-010490.hdr.sgml**: 20260130

**ACCESSION NUMBER**: 0000000000-25-010490

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250925

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LIFECORE BIOMEDICAL, INC. \DE\
- **CENTRAL INDEX KEY:** 0001005286
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 943025618
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0525

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-290460

**BUSINESS ADDRESS:**
- **STREET 1:** 3515 LYMAN BOULEVARD
- **CITY:** CHASKA
- **STATE:** MN
- **ZIP:** 55318
- **BUSINESS PHONE:** 9523684300

**MAIL ADDRESS:**
- **STREET 1:** 3515 LYMAN BOULEVARD
- **CITY:** CHASKA
- **STATE:** MN
- **ZIP:** 55318

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LANDEC CORP \CA\
- **DATE OF NAME CHANGE:** 19951222
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001628280-25-042389

## Text-Extract

```

                                                           September 25, 2025

Tom Salus
Chief Legal and Administration Officer
Lifecore Biomedical, Inc.
3515 Lyman Boulevard
Chaska, MN 55318

       Re: Lifecore Biomedical, Inc.
           Registration Statement on Form S-3
           Filed September 23, 2025
           File No. 333-290460
Dear Tom Salus:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Daniel Crawford at 202-551-7767 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:   Ross McAloon, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._